What does closing on your terms mean?
Closing on your terms means agreeing a settlement built on the validated exposure rather than the preliminary number, and on release language you have read as carefully as the price. By the time you reach the close, a line by line review has already corrected the virtualization overcounts, the incidental options activation, the core factors, and the missed entitlements, and that review typically cuts the claim 60 to 80 percent. The close is where you convert that corrected position into a signed agreement that ends the audit cleanly and does not seed the next one.
The discipline at this stage is to resist the pull of the opening number entirely. Oracle will reference the large preliminary figure as the thing you are being relieved of, but the preliminary report was an opening position, not a debt. The only number that should anchor the settlement is the validated one. Everything else is framing.
Why split the finding from the deal?
You split the finding from the deal because they are two different negotiations, and merging them lets Oracle price one with the other. Oracle frequently offers to make a finding disappear in exchange for a forward commitment, a Unlimited License Agreement, an Oracle Cloud Infrastructure commitment, or a Java SE Universal Subscription. That can be a sensible outcome, but only when the forward purchase is something you would want on its own and is priced against the validated exposure, not the opening number. Keep two ledgers. One settles the audited period at the corrected figure. The other evaluates any forward deal on its own merits and your own roadmap.
A waiver of an inflated finding is worth only what the finding was actually worth once validated. Measure every offered concession against the corrected number, never the opening one.
Why read the release language closely?
You read the release language closely because the words that close the audit decide what you are actually protected from. A good settlement gives a clear release for the audited period, records the corrected entitlements and agreed metrics, and states plainly that the matter is concluded. A weak one settles a number without a release, or releases a narrow slice while leaving the rest of the estate open. The price is only half the document. The scope of the release is the other half, and it is the half that determines whether this audit is truly over or merely paused.
How do forward terms quietly widen obligations?
Forward terms widen obligations quietly when a settlement bundles in metric changes, repricing, or commitments that outlast the audit. Watch for shifts that look administrative but change your position: a metric redefinition, a support recommitment, a cloud consumption target, or a Java subscription scoped to all employees and contractors regardless of use. Each can be reasonable in the right deal, but none should ride into a settlement unexamined. The audit close should end an exposure, not silently create a new one. For the renewal dynamics that often follow, see the Oracle negotiation guide.
What is the buyer move?
The buyer move is to anchor the settlement to the validated exposure, keep any forward deal on a separate ledger, and read the release as carefully as the price. Confirm the corrected entitlements and metrics in the document, secure a clear release for the audited period, and refuse to let an inflated preliminary number frame what relief is worth. This is the final stage of the playbook that began by controlling the clock, the scope, and the data, then validating the findings line by line. For the full sequence, read the Oracle audit defense playbook and validating Oracle's findings line by line, or the complete Oracle audit defense guide.
If you are near the close of an audit, a buyer side review of the settlement and release language protects the reduction you have earned. We reduce your Oracle exposure or we reimburse our service fee, on a Fixed Fee or Gainshare basis with no risk to you.
FAQ
What does closing on your terms mean? Settling against the validated exposure rather than the opening number, after a line by line review has cut the claim 60 to 80 percent, and keeping any forward purchase separate from the finding.
Should I sign a ULA to close? Only if it is priced against the validated exposure and fits your roadmap. A waiver of an inflated finding is worth only what the finding was actually worth once validated.
What should the settlement include? A clear release for the audited period, the corrected entitlements, the agreed metrics, and forward terms that do not silently widen your obligations. Read the release language as carefully as the price.